A detailed history of Montag A & Associates Inc transactions in Haleon PLC stock. As of the latest transaction made, Montag A & Associates Inc holds 3,755 shares of HLN stock, worth $34,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,755
Previous 3,755 -0.0%
Holding current value
$34,771
Previous $31,000 25.81%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$8.04 - $9.0 $6,287 - $7,038
-782 Reduced 17.24%
3,755 $31,000
Q1 2023

May 11, 2023

SELL
$7.57 - $8.37 $3,785 - $4,185
-500 Reduced 9.93%
4,537 $36,000
Q4 2022

Feb 02, 2023

SELL
$5.96 - $8.06 $2,497 - $3,377
-419 Reduced 7.68%
5,037 $40,000
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.5 $30,717 - $40,920
5,456 New
5,456 $33,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $42.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.